FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2593757499> ?p ?o ?g. }

• W2593757499 abstract "Background: Breast cancer is the most common cancer and second leading cause of cancer death among women in the United States (US).1 Inherited mutations in germline breast cancer susceptibility gene 1 and 2 (gBRCAm) are associated with increased risk of developing cancers, including breast cancer.2 No published reports of gBRCAm incidence within an unselected US breast cancer population are available based on a comprehensive literature review (CLR). The main objective of this analysis is to estimate the incidence of gBRCAm breast cancer in the US. Methods: For this analysis the Surveillance, Epidemiology, and End Results (SEER) Program 18 registries captured incidence of breast cancer by stage, age and gender.3 The size of the US population was based on United Nation9s population projections and standardized to the 2010 population.4 Age-specific gBRCAm distribution and gBRCAm-specific hormonal subtype for estrogen-receptor and progesterone-receptor (ER/PR), and human epidermal growth factor receptor-2 (HER2) estimates were determined from a CLR.5-8 Tumor cells negative for ER/PR and HER2 are referred to as triple-negative breast cancer (TNBC). Results: In 2016, it is projected that approximately 250,000 individuals will be diagnosed with invasive breast cancer (all genders). Median age range of the population with invasive breast cancer is 65-69 years and 99% are females. Majority (72%) of female invasive breast cancer cases are ER/PR+ whereas 11% of cases are TNBC. Corroborating with current publications, gBRCAm is estimated at 5% for individuals less than 50 years old and 1% among all ages. Median age range of the gBRCAm cohort is 40-44 years. After applying currently available gBRCAm specific literature parameters, the majority (55%) of gBRCAm diagnoses are TNBC. Conclusion: In the US, patients with gBRCAm represent a small proportion (1%) of all breast cancer tissues evaluated. Majority of gBRCAm patients are diagnosed with TNBC (55%) and are younger (median age range 40-44 years) than overall breast cancer population. Age differences noticed in gBRCAm may have been due to disparity in genetic screening practices among breast cancer population in the US rather than a reflection of gBRCAm expressions. These estimates of gBRCAm incidence are driven by limited reports on an unselected population of breast cancer gBRCAm cohort; therefore sensitivity analysis is required to assess the robustness of these estimates. 1. American Cancer Society. Facts and Figures 2016. 2. Miki Y et al. Science. 1994;266:66-71. 3. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data (1973-2013), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2016, based on the November 2015 submission. 4. United Nations Population Division. World Population Prospects, the 2015 Revision. http://esa.un.org/unpd/wpp/. 5. van den Broek et al. Eur J Hum Genet. 2015;23:588-95. 6.Turkovic L et al. BMC Cancer. 2010;10:466. 7. Atchley DP et al. J Clin Oncol. 2008;26:4282-4321. 8. Spurdle AB et al. Breast Cancer Res. 2014;16:3419. Citation Format: Kim R, Peterson A, Isherwood A, Uppal H, Barlev A. Incidence of germline BRCA1- and BRCA2-mutated breast cancer in the US [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P5-08-28." @default.
• W2593757499 created "2017-03-16" @default.
• W2593757499 creator A5007760476 @default.
• W2593757499 creator A5011585957 @default.
• W2593757499 creator A5013680906 @default.
• W2593757499 creator A5018893097 @default.
• W2593757499 creator A5037838164 @default.
• W2593757499 date "2017-02-14" @default.
• W2593757499 modified "2023-09-28" @default.
• W2593757499 title "Abstract P5-08-28: Incidence of germlineBRCA1-andBRCA2-mutated breast cancer in the US" @default.
• W2593757499 doi "https://doi.org/10.1158/1538-7445.sabcs16-p5-08-28" @default.
• W2593757499 hasPublicationYear "2017" @default.
• W2593757499 type Work @default.
• W2593757499 sameAs 2593757499 @default.
• W2593757499 citedByCount "0" @default.
• W2593757499 crossrefType "proceedings-article" @default.
• W2593757499 hasAuthorship W2593757499A5007760476 @default.
• W2593757499 hasAuthorship W2593757499A5011585957 @default.
• W2593757499 hasAuthorship W2593757499A5013680906 @default.
• W2593757499 hasAuthorship W2593757499A5018893097 @default.
• W2593757499 hasAuthorship W2593757499A5037838164 @default.
• W2593757499 hasConcept C120665830 @default.
• W2593757499 hasConcept C121332964 @default.
• W2593757499 hasConcept C121608353 @default.
• W2593757499 hasConcept C126322002 @default.
• W2593757499 hasConcept C143998085 @default.
• W2593757499 hasConcept C2780110267 @default.
• W2593757499 hasConcept C2908647359 @default.
• W2593757499 hasConcept C29456083 @default.
• W2593757499 hasConcept C530470458 @default.
• W2593757499 hasConcept C61511704 @default.
• W2593757499 hasConcept C71924100 @default.
• W2593757499 hasConcept C84606932 @default.
• W2593757499 hasConcept C99454951 @default.
• W2593757499 hasConceptScore W2593757499C120665830 @default.
• W2593757499 hasConceptScore W2593757499C121332964 @default.
• W2593757499 hasConceptScore W2593757499C121608353 @default.
• W2593757499 hasConceptScore W2593757499C126322002 @default.
• W2593757499 hasConceptScore W2593757499C143998085 @default.
• W2593757499 hasConceptScore W2593757499C2780110267 @default.
• W2593757499 hasConceptScore W2593757499C2908647359 @default.
• W2593757499 hasConceptScore W2593757499C29456083 @default.
• W2593757499 hasConceptScore W2593757499C530470458 @default.
• W2593757499 hasConceptScore W2593757499C61511704 @default.
• W2593757499 hasConceptScore W2593757499C71924100 @default.
• W2593757499 hasConceptScore W2593757499C84606932 @default.
• W2593757499 hasConceptScore W2593757499C99454951 @default.
• W2593757499 hasLocation W25937574991 @default.
• W2593757499 hasOpenAccess W2593757499 @default.
• W2593757499 hasPrimaryLocation W25937574991 @default.
• W2593757499 hasRelatedWork W10138567 @default.
• W2593757499 hasRelatedWork W12399243 @default.
• W2593757499 hasRelatedWork W13747352 @default.
• W2593757499 hasRelatedWork W16158678 @default.
• W2593757499 hasRelatedWork W16909223 @default.
• W2593757499 hasRelatedWork W17538324 @default.
• W2593757499 hasRelatedWork W4675126 @default.
• W2593757499 hasRelatedWork W5413298 @default.
• W2593757499 hasRelatedWork W8093082 @default.
• W2593757499 hasRelatedWork W9366125 @default.
• W2593757499 isParatext "false" @default.
• W2593757499 isRetracted "false" @default.
• W2593757499 magId "2593757499" @default.
• W2593757499 workType "article" @default.